Joel Smalley has been analysing UK annual flu vaccination data. In 2000, national flu vaccination programmes were introduced for those aged over 65.
So, did the flu vaccines save lives?
Not according to Smalley’s analysis. His preliminary analysis suggests the opposite is true. Deaths have increased for those aged over 65 after the flu vaccine was introduced.
Annual flu vaccination programmes were first introduced in England in the late 1960s – vaccination was offered to those in certain clinical risk groups who were at a higher risk of severe illness. It was extended to all people over 65 in 2000. It has since been further extended. By 2018, eligible groups for the flu vaccination included: the over 65s; people with pre-existing serious medical conditions such as diabetes; pregnant women; and those in care homes or other long-stay care facilities.
In 2020, the national flu programme was expanded to include people aged 50 to 64 years and some secondary school year groups. But for the 2023 to 2024 season, healthy 50 to 64-year-olds will not be offered a flu vaccine through the national programme. However, it has been extended to younger age groups; all children aged 2 or 3 years and all primary and secondary school-aged children will be offered a flu vaccine in the 2023 to 2024 flu season.
By Joel Smalley
There are currently no fewer than six flu vaccines available in the UK for everyone aged 6 months and older. But are they necessary and do they actually work?
Using my new mortality model, “Gompertz”, I set out to preliminarily test the hypothesis that the flu campaigns in the UK are beneficial in terms of public health, using empirical data rather than dogmatic assertion.
To keep things concise, and minimise the risk of confounding, I limited this analysis to women born between 1930 and 1950, i.e., aged between 50 and 70 when the public-funded,
Big Pharma advertising public “health” campaigns really ramped up in the year 2000.